Pugs have captured the hearts of dog lovers across India. Their cute wrinkled faces, big round eyes, and loving personalities ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

Insurance companies should not drag their feet. They must take meaningful steps to ensure that obesity treatment is easily ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a ...

Danish pharmaceutical company Novo Nordisk on Tuesday launched its once-weekly injectable weight-loss drug Wegovy in India, at Rs 4,336.25 per dose. Wegovy, a once-weekly glucagon-like peptide-1 ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

For the month so far, FIIs have sold Indian equities worth ₹5,869.04 crore, with gross purchases of ₹172,852.35 crore and gross sales of ₹178,721.39 crore. In contrast, DIIs have emerged as firm ...

Globally, obesity is on the rise, and it is projected that without immediate action, around a third (746 million) of the world’s children and adolescents will be overweight or obese by 2050.

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...